Wall Street has a funny way of looking at the same balance sheet and seeing two entirely different companies. Ahead of Circle’s Q2 earnings on August 5, the analyst community is currently engaged in a high-stakes disagreement over the firm’s future. On one side, you have Morgan Stanley’s James Faucette, who has slashed his price target from $106 to $38, effectively calling for an Underweight position. On the other, TD Cowen’s Bryan Bergin initiated a Buy at $82, while Bernstein’s Gautam Chhugani, despite trimming his target from $190 to $140, remains firmly in the Outperform camp. It is a spread that suggests the market is not just pricing in different growth rates, but fundamentally different business models.
Morgan Stanley’s bear case is built on the idea that Circle is essentially a rate-sensitive utility masquerading as a tech platform. Faucette’s downgrade highlights a harsh reality: as USDC circulation contracts — dropping to $73 billion at the end of Q2 from $77 billion in Q1 — the company’s reliance on reserve income becomes a liability rather than a moat. The argument here is that the business is shifting toward lower-margin transaction revenue, while simultaneously facing existential pressure from tokenized money market funds. If you view Circle as a bank-like entity, the current environment is a slow-motion squeeze.
The bulls, however, see a platform in the middle of a metamorphosis. TD Cowen’s initiation at $82 argues that the market is drastically underestimating Circle’s evolution into a fee-based powerhouse. For Bergin, the value lies in the diversification of revenue streams and the optionality provided by Arc, Circle’s programmable wallet infrastructure. Bernstein’s Chhugani shares this optimism, maintaining an Outperform rating even as he recalibrates his 2028 supply targets downward from $290 billion to $170 billion. To these analysts, the short-term circulation headwinds are merely noise in a much longer-term play for dominance in the digital dollar rails.
Institutional conviction is rarely uniform, but the signal from ARK Invest is worth noting. On July 31, the firm scooped up 109,129 shares of CRCL, a move valued at approximately $6.7 million across its ARKK, ARKW, and ARKF funds. It is a classic contrarian bet, suggesting that while the street debates the margin compression of a shrinking utility, the smart money is betting on the durability of the underlying infrastructure. (Though, as any seasoned observer knows, institutional buying is often less about the next quarter and more about the next decade.)
The tension in the data is palpable. While the capital base has shrunk — with the broader stablecoin market shedding $24 billion from its May peak — transaction volume tells a different story. June saw a record $1.79 trillion in transaction volume, with USDC accounting for $1.21 trillion of that total. This creates a fascinating paradox: the utility is being used more than ever, even as the supply of the underlying asset contracts. Whether this volume can be successfully monetized through high-margin fees is the billion-dollar question.
Circle is clearly betting that its regulatory stack will be the ultimate differentiator. The company has been on a tear, securing an OCC charter on July 10, a suite of IBM patents on July 27, and a NYDFS trust charter on July 31, effectively building the deepest regulatory stack in the stablecoin sector. Yet, even this fortress has its detractors; JPMorgan’s July 14 downgrade, spurred by a revised Hyperliquid agreement that weakened USDC economics, serves as a sharp reminder that regulatory compliance does not automatically equate to margin expansion. The market remains caught between the promise of a compliant, institutional-grade rail and the reality of a business model currently struggling to translate record-breaking transaction volume into bottom-line growth.
August 5 marks the definitive test case for this divergence. As Circle prepares to release its first earnings report since its June 2025 IPO, the numbers will either validate the bull case or confirm the skeptics’ fears. Consensus estimates sit at $744.88 million in revenue — a 13.2% year-over-year increase — and $0.18 in earnings per share, a figure that reflects an 82.4% drop from the previous year. Whether the market chooses to focus on the top-line growth or the EPS contraction will reveal exactly how much patience investors have for the company’s long-term metamorphosis.